Understanding Impact of Pandemic-driven AI on Drug Discovery

An amazing thing to consider: as our CEO Jeff Elton recently wrote in an article for Drug Discovery World, the pharma industry “advanced by five to seven commercial years over the past 18 months due to the pandemic.”

Two years ago, pharma companies weren’t sure that the resources needed to implement AI into their businesses were worth it. The pandemic showed otherwise – and caused an advancement of operations, processes, and clinical innovation that will affect the pharma industry for years to come. How so? Give the piece a read to find out:

Read More